Publisher Correction to: Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Publisher Correction to: Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies ; volume:11 ; number:1 ; day:12 ; month:7 ; year:2023 ; pages:1 ; date:12.2023
Acta Neuropathologica Communications ; 11, Heft 1 (12.7.2023), 1, 12.2023
- Urheber
-
Koga, Shunsuke
Murakami, Aya
Soto-Beasley, Alexandra I.
Walton, Ronald L.
Baker, Matthew C.
Castanedes-Casey, Monica
Josephs, Keith A.
Ross, Owen A.
Dickson, Dennis W.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-023-01621-x
- URN
-
urn:nbn:de:101:1-2023101808375177094357
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Koga, Shunsuke
- Murakami, Aya
- Soto-Beasley, Alexandra I.
- Walton, Ronald L.
- Baker, Matthew C.
- Castanedes-Casey, Monica
- Josephs, Keith A.
- Ross, Owen A.
- Dickson, Dennis W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
TDP-43 Pathology in Alzheimer’s Disease
Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
Molecular fragment characteristics and distribution of tangle associated TDP-43 (TATs) and other TDP-43 lesions in Alzheimer’s disease
C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation
Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation
Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice
TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
The neuropathological diagnosis of Alzheimer’s disease
Regulation of TDP-43 phosphorylation in aging and disease
The effect of TDP-43 antibodies on TDP-43 aggregation and toxicity
Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD–TDP subtypes
TDP-43 Pathology in Alzheimer’s Disease
Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
Molecular fragment characteristics and distribution of tangle associated TDP-43 (TATs) and other TDP-43 lesions in Alzheimer’s disease
C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation
Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation
Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice
TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
The neuropathological diagnosis of Alzheimer’s disease
Regulation of TDP-43 phosphorylation in aging and disease
The effect of TDP-43 antibodies on TDP-43 aggregation and toxicity
Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD–TDP subtypes
TDP-43 Pathology in Alzheimer’s Disease
Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
Molecular fragment characteristics and distribution of tangle associated TDP-43 (TATs) and other TDP-43 lesions in Alzheimer’s disease
C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation
Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation
Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice
TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
The neuropathological diagnosis of Alzheimer’s disease
Regulation of TDP-43 phosphorylation in aging and disease
The effect of TDP-43 antibodies on TDP-43 aggregation and toxicity